Cover Story
By Claire Dietz and Paul Goldberg
Pharmacy benefit managers, like climate change, germs and, possibly, God, are all around, and if we could clear a few hours, it would be good to learn enough about them to sustain a cocktail party conversation.
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
NCI Trials
NCI Trials for April
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- Trump 2016: A look back at the 45th president’s impact on oncology
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Trump to dedicate $500M over 10 years to childhood cancer
- The Cancer Letter’s most-read stories of 2024
- The unKOOL, unfiltered history of menthol cigarettes
- What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.”